Literature DB >> 9343177

Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral glycoproteins, expressed on pseudorabies virus-infected cells.

H W Favoreel1, H J Nauwynck, P Van Oostveldt, T C Mettenleiter, M B Pensaert.   

Abstract

Fluorescein isothiocyanate-labeled porcine pseudorabies virus (PrV) polyclonal antibodies were added to PrV-infected swine kidney cells in vitro at 37 degrees C. In approximately 47% of the infected cells, the addition induced passive patching and subsequent energy- and microtubule-dependent capping of all viral envelope glycoproteins, expressed on the plasma membranes of the infected cells. Further contraction and extrusion of the capped viral glycoproteins occurred in approximately 30% of the capped cells 2 h after the addition of antibodies and was accompanied by a concentration of F-actin beneath the caps. At that time, about 18% of the extruded caps were shed spontaneously into the surrounding medium. Mechanical force released 85% of the extruded caps, leaving viable cells with no microscopically detectable levels of viral glycoproteins on their plasma membranes. Experiments with PrV deletion mutants showed that viral glycoproteins gE and gI are important in triggering viral glycoprotein redistribution. Since the PrV gE-gI complex exhibits Fc receptor activity which facilitates capping, the importance of gE and gI may be partially explained by antibody bipolar bridging.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343177      PMCID: PMC192283     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Herpesviruses--immune escape artists?

Authors:  T A Banks; B T Rouse
Journal:  Clin Infect Dis       Date:  1992-04       Impact factor: 9.079

2.  Microtubule organization of lymphocytes and its modulation by patch and cap formation.

Authors:  I Yakara; F Kakimoto-Sameshima
Journal:  Cell       Date:  1978-09       Impact factor: 41.582

3.  Identification and characterization of pseudorabies virus glycoprotein gM as a nonessential virion component.

Authors:  J M Dijkstra; N Visser; T C Mettenleiter; B G Klupp
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  Myosin II is involved in capping and uroid formation in the human pathogen Entamoeba histolytica.

Authors:  P Arhets; P Gounon; P Sansonetti; N Guillén
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

6.  Cell-free and cell-associated viremia in pigs after oronasal infection with Aujeszky's disease virus.

Authors:  H J Nawynck; M B Pensaert
Journal:  Vet Microbiol       Date:  1995-03       Impact factor: 3.293

7.  Involvement of membrane-bound viral glycoproteins in adhesion of pseudorabies virus-infected cells.

Authors:  F P Hanssens; H J Nauwynck; M B Pensaert
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration.

Authors:  I Rauh; T C Mettenleiter
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization, and cytoskeletal association.

Authors:  J Martin; B Sugden
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

10.  Identification and characterization of pseudorabies virus glycoprotein H.

Authors:  B G Klupp; N Visser; T C Mettenleiter
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more
  25 in total

1.  Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Replication of herpes simplex virus: egress of progeny virus at specialized cell membrane sites.

Authors:  Rebecca M Mingo; Jun Han; William W Newcomb; Jay C Brown
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Responses of herpes simplex virus type 1-infected cells to the presence of extracellular antibodies: gE-dependent glycoprotein capping and enhancement in cell-to-cell spread.

Authors:  Syed Monem Rizvi; Malini Raghavan
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Role of envelope protein gE endocytosis in the pseudorabies virus life cycle.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

Review 5.  Herpesvirus Evasion of Natural Killer Cells.

Authors:  Steffi De Pelsmaeker; Nicolas Romero; Massimo Vitale; Herman W Favoreel
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

6.  Copatching and lipid raft association of different viral glycoproteins expressed on the surfaces of pseudorabies virus-infected cells.

Authors:  Herman W Favoreel; Thomas C Mettenleiter; Hans J Nauwynck
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G.

Authors:  Elizabeth R Sprague; Henrike Reinhard; Evelyn J Cheung; Alexander H Farley; Robin Deis Trujillo; Hartmut Hengel; Pamela J Bjorkman
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

8.  The disulfide-bonded structure of feline herpesvirus glycoprotein I.

Authors:  J D Mijnes; B C Lutters; A C Vlot; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

Review 9.  Complement and its role in protection and pathogenesis of flavivirus infections.

Authors:  Panisadee Avirutnan; Erin Mehlhop; Michael S Diamond
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

10.  Functional impairment of PRRSV-specific peripheral CD3+CD8high cells.

Authors:  Sarah Costers; David J Lefebvre; Bruno Goddeeris; Peter L Delputte; Hans J Nauwynck
Journal:  Vet Res       Date:  2009-05-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.